Efficacy and Safety of Vutrisiran in Patients with Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy: Analysis of the East Asian Subpopulation from HELIOS-A

Oh, JeeyoungJeeyoungOhSekijima, YoshikiYoshikiSekijimaMochizuki, HidekiHidekiMochizukiJoon Kim, ByoungByoungJoon KimMin, Ju-HongJu-HongMinKatsuno, MasahisaMasahisaKatsunoYin Tan, ChengChengYin TanLee, Yi-ChungYi-ChungLeeMisumi, YoheiYoheiMisumiZhao, WeizhiWeizhiZhaoChan-Daniels, AmyAmyChan-DanielsCHI-CHAO CHAO2026-03-162026-03-162026-03-04https://scholars.lib.ntu.edu.tw/handle/123456789/736337enPolyneuropathyQuality of lifeTransthyretin amyloidosisVutrisiranEfficacy and Safety of Vutrisiran in Patients with Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy: Analysis of the East Asian Subpopulation from HELIOS-Atext::journal::journal article10.1007/s40120-026-00899-y41779098